{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T08:52:04Z","timestamp":1793350324259,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T00:00:00Z","timestamp":1686528000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T00:00:00Z","timestamp":1686528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100005612","name":"Shionogi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005612","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s12325-023-02564-4","type":"journal-article","created":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T03:10:48Z","timestamp":1686539448000},"page":"3525-3542","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Estimation of Intangible Costs for Factors Associated with Oral Antiviral Drugs for COVID-19 Treatment: A Conjoint Analysis in Japan"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3229-2277","authenticated-orcid":false,"given":"Naoki","family":"Hosogaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0696-5386","authenticated-orcid":false,"given":"Takahiro","family":"Takazono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1678-0446","authenticated-orcid":false,"given":"Kenji","family":"Kurazono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0015-4793","authenticated-orcid":false,"given":"Shinzo","family":"Hiroi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0572-5145","authenticated-orcid":false,"given":"Tomomi","family":"Takeshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chise","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1429-5706","authenticated-orcid":false,"given":"Hiroshi","family":"Mukae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,12]]},"reference":[{"key":"2564_CR1","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1080\/13696998.2021.1877150","volume":"24","author":"N Hosogaya","year":"2021","unstructured":"Hosogaya N, Takazono T, Yokomasu A, et al. Estimation of the value of convenience in taking influenza antivirals in Japanese adult patients between baloxavir marboxil and neuraminidase inhibitors using a conjoint analysis. J Med Econ. 2021;24:244\u201354.","journal-title":"J Med Econ"},{"key":"2564_CR2","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1007\/s12325-022-02062-z","volume":"39","author":"K Kurazono","year":"2022","unstructured":"Kurazono K, Ikeoka H, Hiroi S, et al. Comparison of inconvenience costs between influenza antivirals for japanese pediatric patients: a conjoint analysis of parental responses. Adv Ther. 2022;39:1724\u201342.","journal-title":"Adv Ther"},{"key":"2564_CR3","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.jval.2010.11.013","volume":"14","author":"JF Bridges","year":"2011","unstructured":"Bridges JF, Hauber AB, Marshall D, et al. Conjoint analysis applications in health\u2014a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force. Value Health. 2011;14:403\u201313.","journal-title":"Value Health"},{"key":"2564_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ssmph.2021.100902","volume":"15","author":"K Kawata","year":"2021","unstructured":"Kawata K, Nakabayashi M. Determinants of COVID-19 vaccine preference: a survey study in Japan. SSM Popul Health. 2021;15: 100902.","journal-title":"SSM Popul Health"},{"key":"2564_CR5","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1080\/14760584.2022.2016402","volume":"21","author":"A Igarashi","year":"2022","unstructured":"Igarashi A, Nakano Y, Yoneyama-Hirozane M. Public preferences and willingness to accept a hypothetical vaccine to prevent a pandemic in Japan: a conjoint analysis. Expert Rev Vaccines. 2022;21:241\u20138.","journal-title":"Expert Rev Vaccines"},{"key":"2564_CR6","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.25594","volume":"3","author":"S Kreps","year":"2020","unstructured":"Kreps S, Prasad S, Brownstein JS, et al. Factors associated with US adults\u2019 likelihood of accepting COVID-19 vaccination. JAMA Netw Open. 2020;3: e2025594.","journal-title":"JAMA Netw Open"},{"key":"2564_CR7","doi-asserted-by":"publisher","first-page":"e210","DOI":"10.1016\/S2468-2667(21)00012-8","volume":"6","author":"M Schwarzinger","year":"2021","unstructured":"Schwarzinger M, Watson V, Arwidson P, et al. COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics. Lancet Public Health. 2021;6:e210\u201321.","journal-title":"Lancet Public Health"},{"key":"2564_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2020.113642","volume":"272","author":"M Motta","year":"2021","unstructured":"Motta M. Can a COVID-19 vaccine live up to Americans\u2019 expectations? A conjoint analysis of how vaccine characteristics influence vaccination intentions. Soc Sci Med. 2021;272: 113642.","journal-title":"Soc Sci Med"},{"key":"2564_CR9","unstructured":"[Guidelines for Diagnosis and Treatment of COVID 19, ver. 9.0] [Internet]. Tokyo (Japan): Ministry of Health, Labour and Welfare; 2023. [cited 2023 Mar 17]; Available from: https:\/\/www.mhlw.go.jp\/content\/000936655.pdf. Japanese."},{"key":"2564_CR10","unstructured":"Report on the Deliberation Results. Lagevrio Capsules 200 mg [Internet]. Tokyo (Japan): Pharmaceutical Evaluation Division, Pharmaceutical Safety and Environmental Health Bureau; 2021. [cited 2023 Mar 17]; Available from: https:\/\/www.pmda.go.jp\/files\/000245005.pdf."},{"key":"2564_CR11","unstructured":"Report on the Deliberation Results. Paxlovid PACK [Internet]. Tokyo (Japan): Pharmaceutical Evaluation Division, Pharmaceutical Safety and Environmental Health Bureau; 2022. [cited 2023 Mar 17]; Available from: https:\/\/www.pmda.go.jp\/files\/000246305.pdf."},{"key":"2564_CR12","unstructured":"Report on the Deliberation Results. Xocova Tablets 125 mg [Internet]. Tokyo (Japan): Pharmaceutical Evaluation Division, Pharmaceutical Safety and Environmental Health Bureau November; 2022. [cited 2023 Mar 17]; Available from: https:\/\/www.pmda.go.jp\/files\/000249828.pdf."},{"key":"2564_CR13","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1016\/S1473-3099(22)00507-2","volume":"22","author":"CKH Wong","year":"2022","unstructured":"Wong CKH, Au ICH, Lau KTK, et al. Real-world effectiveness of early molnupiravir or nirmatrelvir-ritonavir in hospitalised patients with COVID-19 without supplemental oxygen requirement on admission during Hong Kong\u2019s omicron BA.2 wave: a retrospective cohort study. Lancet Infect Dis. 2022;22:1681\u201393.","journal-title":"Lancet Infect Dis"},{"key":"2564_CR14","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.3390\/v14112514","volume":"14","author":"G Bruno","year":"2022","unstructured":"Bruno G, Giotta M, Perelli S, et al. Early access to oral antivirals in high-risk outpatients: good weapons to fight COVID-19. Viruses. 2022;14:2514.","journal-title":"Viruses"},{"key":"2564_CR15","unstructured":"Ethical Guidelines for Life Science and Medical Research Involving Human Subjects. Tokyo (Japan); The Ministry of Education, Sports, Science and Technology; The Ministry of Health, Labor and Welfare, 2021, partial revision in 2023."},{"key":"2564_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-055725","volume":"12","author":"S Li","year":"2022","unstructured":"Li S, Gong T, Chen G, et al. Parental preference for influenza vaccine for children in China: a discrete choice experiment. BMJ Open. 2022;12: e055725.","journal-title":"BMJ Open"},{"key":"2564_CR17","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.foodqual.2016.03.001","volume":"56","author":"K Aoki","year":"2017","unstructured":"Aoki K, Akai K, Ujiie K. A choice experiment to compare preferences for rice in Thailand and Japan: the impact of origin, sustainability, and taste. Food Qual Prefer. 2017;56:274\u201384.","journal-title":"Food Qual Prefer"},{"key":"2564_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.meatsci.2022.108879","volume":"192","author":"K Sasaki","year":"2022","unstructured":"Sasaki K, Motoyama M, Watanabe G, et al. Meat consumption and consumer attitudes in Japan: an overview. Meat Sci. 2022;192: 108879.","journal-title":"Meat Sci"},{"key":"2564_CR19","doi-asserted-by":"publisher","first-page":"327","DOI":"10.2508\/chikusan.90.327","volume":"90","author":"F Wang","year":"2019","unstructured":"Wang F, Huang S, Yamano H, et al. A comparative survey of consumer behavior and preferences in relation to pork consumption in Japan and China. Nihon Chikusan Gakkaiho. 2019;90:327\u201335 (Japanese).","journal-title":"Nihon Chikusan Gakkaiho"},{"key":"2564_CR20","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.foodpol.2013.10.002","volume":"44","author":"H Uchida","year":"2014","unstructured":"Uchida H, Onozaka Y, Morita T, Managi S. Demand for ecolabeled seafood in the Japanese market: a conjoint analysis of the impact of information and interaction with other labels. Food Policy. 2014;44:68\u201376.","journal-title":"Food Policy"},{"key":"2564_CR21","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.1108\/BFJ-10-2019-0762","volume":"122","author":"H Aizaki","year":"2020","unstructured":"Aizaki H, Sato K. Consumer preferences for three dimensions of country of origin of a processed food product. Br Food J. 2020;122:3361\u201382.","journal-title":"Br Food J"},{"key":"2564_CR22","unstructured":"[About development status] [Internet]. Tokyo (Japan): Ministry of Health, Labour and Welfare; 2022. [cited 2023 Mar 17]; Available from: https:\/\/www.mhlw.go.jp\/stf\/seisakunitsuite\/bunya\/0000121431_00223.html. Japanese."},{"key":"2564_CR23","unstructured":"[List of New Drugs (to be listed on March 15, 2023)] [Internet]. Tokyo (Japan): Ministry of Health, Labour and Welfare; 2023. [cited 2023 Mar 17]; Available from: https:\/\/www.mhlw.go.jp\/content\/12404000\/001068235.pdf. Japanese."},{"key":"2564_CR24","unstructured":"[List of New Drugs (to be listed on August 18, 2022)] [Internet]. Tokyo (Japan): Ministry of Health, Labour and Welfare; 2022. [cited 2023 Mar 17]; Available from: https:\/\/www.mhlw.go.jp\/content\/12404000\/000974956.pdf. Japanese."}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-023-02564-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-023-02564-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-023-02564-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T03:24:10Z","timestamp":1688959450000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-023-02564-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,12]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["2564"],"URL":"https:\/\/doi.org\/10.1007\/s12325-023-02564-4","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,12]]},"assertion":[{"value":"27 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}